申请人:PFIZER INC.
公开号:US20140135339A1
公开(公告)日:2014-05-15
The invention relates to compounds of formula (Φ)
as further defined herein and to the pharmaceutically acceptable salts thereof, to pharmaceutical compositions comprising such compounds and salts, and to the uses thereof. The compounds and salts of the present invention inhibit anaplastic lymphoma kinase (ALK) and/or EML4-ALK and are useful for treating or ameliorating abnormal cell proliferative disorders, such as cancer.
本发明涉及以下公式(Φ)所定义的化合物及其药学上可接受的盐,包括含有这些化合物和盐的药物组合物,以及它们的用途。本发明的化合物和盐抑制无形淋巴瘤激酶(ALK)和/或EML4-ALK,并可用于治疗或改善异常细胞增殖性疾病,如癌症。